Ambarella Inc.
AMBA
$68.80
+8.38%
Ambarella, Inc. is a fabless semiconductor company that designs low-power system-on-a-chip (SoC) solutions and software for edge and physical AI applications, including video security cameras, automotive camera systems, robots, and consumer devices like drones and action cameras. As a niche player in the edge AI semiconductor market, Ambarella differentiates itself through its focus on energy-efficient AI processing and computer vision capabilities, competing with larger players like NVIDIA and Qualcomm. The current investor narrative centers on Ambarella's strategic pivot toward edge AI and physical AI applications, which has attracted Wall Street confidence and a recent price target increase to $120, despite the company still grappling with profitability challenges and a competitive landscape. Recent quarterly results beat estimates, but the stock has underperformed the broader market, reflecting ongoing debate about its growth trajectory and valuation.…
AMBA
Ambarella Inc.
$68.80
Related headlines
Investment Opinion: Should I buy AMBA Today?
Rating: Hold. Ambarella is a promising edge AI player with strong revenue recovery and gross margins, but its persistent losses and high valuation warrant caution. The analyst consensus is 'buy' with an average target of $95, implying 51% upside, but the stock's underperformance suggests the market is skeptical. I would rate it a Hold, as the risk-reward is balanced until profitability improves.
Sign up to view all
AMBA 12-Month Price Forecast
The AI assessment is neutral, as the company shows solid revenue recovery and gross margins, but profitability remains elusive. The high forward PE suggests the market is pricing in a successful turnaround, which is not yet evident. If Ambarella can achieve positive operating income within the next two quarters, the stance would upgrade to bullish. Conversely, if revenue growth decelerates below 10% or losses widen, the stance would turn bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ambarella Inc.'s 12-month outlook, with a consensus price target around $89.36 and implied upside of +29.9% versus the current price.
Average Target
$89.36
0 analysts
Implied Upside
+29.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $120
Analyst target range
The target price range spans from a low of $80.00 to a high of $120.00, with the average at $95.00. The high target of $120 implies a 91% upside, likely assuming successful execution in edge AI markets and margin expansion, while the low target of $80 suggests a more conservative scenario with potential competitive pressures or slower growth. The wide spread of $40 between low and high indicates high uncertainty about the company's future performance. Recent news highlights a new $120 price target from an analyst, reflecting growing confidence in Ambarella's edge AI strategy, but the stock's underperformance relative to the market suggests that some investors remain skeptical about near-term catalysts.
Bulls vs Bears: AMBA Investment Factors
Ambarella presents a mixed picture: strong revenue recovery and healthy gross margins are offset by persistent losses and a rich valuation. The bull case hinges on successful execution in edge AI, while the bear case focuses on profitability and competitive threats. Currently, the bear side has slightly stronger evidence given the stock's underperformance and high valuation, but the company's strategic pivot could shift the balance. The most critical tension is whether Ambarella can translate its revenue growth into sustainable profitability, as this determines if the forward PE of 56x is justified or overly optimistic.
Bullish
- Revenue recovery with 16.87% YoY growth: Q1 FY2027 revenue reached $100.36M, up 16.87% YoY from $85.87M, marking the fourth consecutive quarter of YoY growth. This indicates a cyclical recovery from the FY2025 trough, driven by new edge AI products.
- Strong gross margin at 59.13%: Gross margin improved to 59.13% in Q1 FY2027, up from 58.73% in the prior quarter and 58.73% in Q1 FY2026. This demonstrates pricing power and a favorable product mix, supporting potential profitability as revenue scales.
- Healthy balance sheet with low debt: Debt-to-equity is only 0.023, and current ratio is 2.31, indicating ample liquidity and minimal financial risk. This provides a cushion for continued R&D investment without distress.
- Positive free cash flow of $26.2M TTM: Despite GAAP losses, free cash flow is positive at $26.2M TTM, showing operational efficiency and ability to fund growth internally. This reduces reliance on external financing.
Bearish
- Persistent GAAP losses and negative margins: Net income was -$18.1M in Q1 FY2027, with a net margin of -18.0% and operating margin of -18.1%. Despite revenue growth, the company remains unprofitable, and the path to profitability is unclear.
- High valuation with forward PE of 56x: The forward PE of 56.12x is steep, implying the market expects significant earnings growth. If profitability is delayed, the stock could face de-rating. The PS ratio of 7.0x is also above historical norms.
- Stock underperforming market significantly: AMBA is down 22.54% over the past year versus S&P 500 up 18.65%, a relative underperformance of over 41 percentage points. This suggests persistent investor skepticism about growth and profitability.
- Revenue deceleration sequentially: Q1 FY2027 revenue of $100.36M was slightly below Q4 FY2026's $100.87M, indicating a sequential decline. This could signal that the recovery is plateauing, raising doubts about sustained growth.
AMBA Technical Analysis
Ambarella's stock has experienced a volatile year, with a 1-year price change of -22.54%, contrasting sharply with the S&P 500's +18.65% gain over the same period. The current price of $62.89 sits at 65% of the 52-week range (low $48.30, high $96.69), indicating a significant pullback from its highs but still above its lows. This positioning suggests the stock is in a corrective phase after a strong rally, with the 52-week high reached in May 2026 followed by a sharp decline, reflecting a bearish trend over the past year.
Beta
2.09
2.09x market volatility
Max Drawdown
-49.1%
Largest decline past year
52-Week Range
$48-$97
Price range past year
Annual Return
-18.7%
Cumulative gain past year
| Period | AMBA Return | S&P 500 |
|---|---|---|
| 1m | -16.1% | -1.4% |
| 3m | +4.6% | +3.3% |
| 6m | +31.6% | +15.1% |
| 1y | -18.7% | +17.2% |
| ytd | -8.5% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMBA Fundamental Analysis
Ambarella's revenue trajectory shows a recovery from a trough, with the most recent quarter (Q1 FY2027, ending April 30, 2026) reporting revenue of $100.36 million, a 16.87% YoY increase from $85.87 million in the prior-year quarter. This marks the fourth consecutive quarter of YoY growth, following a period of decline in FY2025, indicating a cyclical recovery. However, growth is decelerating sequentially, with Q1 FY2027 revenue slightly down from Q4 FY2026's $100.87 million, and the company's revenue segments are not provided, so it's unclear which product lines are driving growth. The recovery is likely driven by new edge AI products, but the sustainability of this growth remains a key question.
Quarterly Revenue
$100357000.0B
2026-04
Revenue YoY Growth
+16.9%
YoY Comparison
Gross Margin
59.1%
Latest Quarter
Free Cash Flow
$26233000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMBA Overvalued?
Given that Ambarella's trailing twelve-month net income is negative (EPS of -$0.41 in the latest quarter), the price-to-earnings (PE) ratio is not meaningful, so I selected the price-to-sales (PS) ratio as the primary valuation metric. The current PS ratio is 7.0x, based on a market cap of $2.73 billion and trailing revenue of approximately $390 million. The forward PE ratio is 56.12x, implying that the market expects significant earnings growth in the next fiscal year, which is optimistic given the company's current losses. The gap between the negative trailing PE and the positive forward PE suggests the market is pricing in a substantial turnaround, which may be overly optimistic if the company fails to achieve profitability.
PE
-36.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-53.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are significant: Ambarella has negative net income and operating margins, with a net margin of -18.0% and operating margin of -18.1% in Q1 FY2027. The company's reliance on continued revenue growth to achieve profitability is risky, as any slowdown could prolong losses. However, the balance sheet is strong with a debt-to-equity of 0.023 and current ratio of 2.31, providing a buffer. Free cash flow is positive at $26.2M TTM, but the company is still burning cash on a GAAP basis, and if growth stalls, cash burn could resume.
FAQ
Key risks include: 1) Financial risk: Persistent GAAP losses with a net margin of -18.0%, which could continue if revenue growth stalls. 2) Competitive risk: Intense competition from NVIDIA and Qualcomm, which have more resources and could limit market share. 3) Valuation risk: A high forward PE of 56x leaves little room for error; any disappointment could lead to a sharp de-rating. 4) Macro risk: The stock has a beta of 1.2, making it sensitive to market downturns. The most severe risk is a prolonged period of unprofitability, which could erode investor confidence and drive the stock down to its 52-week low of $48.30.
The 12-month forecast is mixed. In the bull case (25% probability), the stock could reach $95-$120, driven by strong edge AI adoption and profitability progress. In the base case (50% probability), the stock is expected to trade in the $80-$95 range, reflecting steady growth but continued losses. In the bear case (25% probability), the stock could fall to $48-$65 if growth decelerates and losses persist. The most likely scenario is the base case, with the stock moving toward the analyst average target of $95, assuming revenue growth continues in the mid-teens.
AMBA is trading at a forward PE of 56x and a PS ratio of 7.0x, which are premium to many semiconductor peers. The market is pricing in significant earnings growth, which is optimistic given the company's current losses. Compared to its own history, the PS ratio is above the 5-year average, suggesting the stock is not cheap. The valuation implies that investors expect a successful turnaround and strong growth in edge AI. If the company fails to deliver, the stock could be considered overvalued.
AMBA is a high-risk, high-reward stock. The analyst consensus is 'buy' with an average target of $95, implying 51% upside from the current price of $62.89. However, the company is unprofitable, with a net margin of -18.0%, and the stock has underperformed the market over the past year. It could be a good buy for investors with a long-term horizon who believe in the edge AI growth story and can tolerate volatility. For conservative investors, it may be better to wait for evidence of sustained profitability or a lower entry point.
AMBA is more suitable for long-term investment, given its growth stage and volatility. The company is investing heavily in edge AI, which could take several years to translate into profitability. Short-term trading is risky due to high volatility, as seen in the 23% drop in the past month. For long-term investors, a minimum holding period of 3-5 years is recommended to allow the edge AI strategy to play out. The stock has no dividend, so returns depend on capital appreciation, which requires patience and a tolerance for drawdowns.